Industry Leaders Announce World’s First Microphysiological Systems Industry Association (IAMPS)

European microphysiological systems (MPS) industry leaders, AlveoliX (Switzerland); BiomimX (Italy); chiron (Netherlands) Dynamic42 (Germany); InSphero (Switzerland); MIMETAS (Netherlands) NETRI (France), React4Life (Italy) and TissUse (Germany), are announcing today the creation […]

Weiterlesen

New Multi-Organ-Chip project towards vaccine & drug candidate testing for Tuberculosis

TissUse will receive funding from the Bill & Melinda Gates Foundation to develop a human preclinical lung-liver-lymph node co-culture on a HUMIMIC Chip infectable with Mycobacterium tuberculosis. This collaboration will […]

Weiterlesen

Philip Morris International and TissUse develop a human aerosol test platform to emulate the entire human respiratory tract

PMI and TissUse have signed a collaboration agreement to utilize PMI’s InHALES technology in combination with TissUse’s proprietary Multi-Organ-Chip (MOC) platform to enable inhalation exposure of functional human tissues in […]

Weiterlesen

TissUse launcht neue Produktmarkte HUMIMIC

TissUse, die Berliner Pioniere in Human-on-a-Chip Entwicklungen haben Ihre Produktmarke HUMIMIC gelauncht. Unter diesem Brand werden in Zukunft alle Produkte des Unternehmens gebündelt. Unter der Marke HUMIMIC bekommen die Produkte […]

Weiterlesen